NCT02605343View on ClinicalTrials.gov

Prospective Observational Clinical Study to Evaluate Patient Outcomes Following Pharmacogenetic Testing of Patients Undergoing Elective Surgical Procedures

CompletedOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

April 30, 2016

Conditions
Acute PainSurgery
Interventions
OTHER

NeuroIDgenetix Test Panel

The NeuroIDgenetix Test Panel is used to make recommendations on post-operative pain medication therapy that may be impacted by the genetic background of the patient.

Trial Locations (1)

44106

University Hospitals of Cleveland Case Medical Center, Cleveland

Sponsors

Lead Sponsor

AltheaDx
All Listed Sponsors
collaborator

University Hospitals Cleveland Medical Center

OTHER

lead

AltheaDx

INDUSTRY